Thomas Cahill, Director at Prime Medicine, Inc. (PRME), bought 5,305,679 shares at $17.00 ($6.8M) on 2022-10-24, disclosed to the SEC on 2022-10-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,905,679 | $0 | 0.0% |
| 2 | $17.00 | 400,000 | $6.8M | 100.0% |
| Total | $1.28 avg | 5,305,679 | $6.8M | 100% |